Select for export IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.63050/jpps.21.02.935 Copy citation Copy BibTeX Journal of Pakistan Psychiatric Society 2024-06-29 Nauman Ashraf OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.06.25.600634 Copy citation Copy BibTeX bioRxiv 2024-06-28 Brownstien M, Lazar M, Botvinnik A, Shevakh C, Blakolmer K, Lerer L bioRxiv PREPRINT (not peer reviewed) psilocybin AnxietyOCDMechanism of Action Randomized Controlled Trial More
Select for export The cyclical revival of psychedelics in psychiatric treatment. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/03007995.2024.2368725 PubMed 38880945 Copy citation Copy BibTeX Unknown journal 2024-06-19 Appiani FJ, Caroff SN. Europe PMC Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psychres.2024.116018 PubMed 38924903 Copy citation Copy BibTeX Unknown journal 2024-06-19 Guo Q, Guo L, Wang Y, Shang S. Europe PMC Published psilocybin DepressionRandomized Controlled TrialMeta-Analysis Randomized Controlled Trial More
Select for export Licit use of illicit drugs for treating depression: the pill and the process. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1172/jci180217 PubMed 40047885 Copy citation Copy BibTeX Unknown journal 2024-06-16 Torrado Pacheco A, Moghaddam B. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Comparing Cannabis Use Motivations and Dependence Across Regular Cannabis Users Who Have or Have Not Recently Used Psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/can.2024.0059 PubMed 38885938 Copy citation Copy BibTeX Cannabis and Cannabinoid Research 2024-06-16 Madeline Stanger, Harmony O. Soffer, Angela D. Bryan, Carillon J. Skrzynski OpenAlex Published psilocybin AddictionObservational Study Observational Study More
Select for export Psychedelics’ Use as Medicine Hits Significant Roadblock Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.07.7.54 Copy citation Copy BibTeX Psychiatric News 2024-06-11 Linda M. Richmond OpenAlex Published psilocybin DepressionPTSDPharmacology Clinical Trial More
Select for export Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1406888 PubMed 38919636 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-06-10 Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz OpenAlex Published psilocybin DepressionAddictionOCD Clinical Trial More
Select for export Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/adnpg Copy citation Copy BibTeX PsyArXiv 2024-06-09 Petrovitch D, Mitchell SM, Van Allen J, Littlefield AK. PsyArXiv PREPRINT (not peer reviewed) psilocybin AddictionClinical TrialHealthcare Workers Clinical Trial More
Select for export A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-06-09 University of Sydney ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2024-06-09 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAddictionPharmacology Clinical Trial More
Select for export Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/um2cy Copy citation Copy BibTeX PsyArXiv 2024-06-06 Calder A, Hasler G. PsyArXiv PREPRINT (not peer reviewed) psilocybin SafetyAdverse Events Other More
Select for export 5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2024-06-06 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin PTSDPersonality ChangeEmotional Processing Other More
Select for export Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2024-06-06 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin SafetyAdverse Events Other More
Select for export Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/add.16575 PubMed 38845381 Copy citation Copy BibTeX Addiction 2024-06-05 Christina M. Andrews, Wayne Hall, Keith Humphreys, John Marsden OpenAlex Published psilocybin Addiction Other More
Select for export Minorities’ Diminished Psychedelic Returns: Gender, Perceived Stigma, and Distress Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/psychoactives3020019 Copy citation Copy BibTeX Psychoactives 2024-06-01 Sean M. Viña OpenAlex Published psilocybin Receptor PharmacologyObservational Study Observational Study More
Select for export Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jpsychires.2024.05.051 PubMed 38850581 Copy citation Copy BibTeX Unknown journal 2024-05-30 Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES Europe PMC Published psilocybin DepressionEnd-of-Life DistressClinical Trial Randomized Controlled Trial More
Select for export Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/ccr3.8791 PubMed 38813452 Copy citation Copy BibTeX Clinical Case Reports 2024-05-27 Harman Chopra, Timothy Furnish, Monica Verduzco-Gutierrez, David S. Jevotovsky, Joel Castellanos OpenAlex Published psilocybin Case ReportSafety Clinical Trial More
Select for export Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2024-05-25 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin AnxietyNeuroplasticityMechanism of Action Review Article More
Select for export On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.22541/au.171648613.31141136/v1 Copy citation Copy BibTeX Authorea Preprints 2024-05-22 Hoyer D. Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionAnxietyPTSD Clinical Trial More
